EUSRA™

Indication

• Pancreatic tumor (locally advanced pancreatic cancer, pancreatic neuroendocrine tumor, pancreatic cysts, etc)
• Extra pancreatic tumor (liver, adrenal, kidney, GI gyst, etc)

Features

• Feasible and safe ablative treatment for locally advanced unresectable pancreatic cancer, neuroendocrine tumors, and cystic neoplasms
• An easy approach to the target lesion with a great pushability of the needle
• Good echogenicity for safe procedure under EUS-guidance
• Inner cooling system making it possible to ablate large volumes of tumor without tissue charring

• The electrode is a monopolar system and needs ground pads
• Optimal RFA needle operating with VIVA Combo™ generators only

EUS-guided radiofrequency ablation of the porcine pancreas
Gastrointestinal Endoscopy Vol.76, No.5: 2012 Dong-Wan Seo, MD, PhD

Initial experience of EUS-guided radiofrequency ablation of unresectable pancreatic cancer
Gastrointestinal endsocopy 2015 Dong Wan Seo, MD, PhD

EUS-guided radiofrequency ablation for management of pancreatic insulinoma by using a novel needle electrode (with videos)
Gastrointestinal Endsocopy 2015 Sundeep Lakhtakia, MD, DM, MNAMS, FASGE

Endoscopic ultrasound-guided radiofrequency ablation of a pancreatic neuroendocrine tumor
Endsoscopy 2015 Elia Armellini, Stefano F. Crino, Marco Ballare, Pietro Occhipinti, MD, Italy

Electrode radiofrequency ablation EUS-guided-EUSRA™
Giornale Italiano Di Endoscopia Digestiva, Marzo 2017 Elia Armellini et al.

Cushing's syndrome managed by endoscopic ultrasound-guided radiofrequency ablation of adrenal gland adenoma
Endoscopy 2017;49:E1-E2 Dong Wan Seo, MD, PhD